Amador Bioscience Announces the Completion of $60 Million Series B+ Round Financing

PLEASANTON, Calif., Dec. 30, 2021 -- (Healthcare Sales & Marketing Network) -- Amador Bioscience, a global translational sciences and clinical pharmacology CRO, announced today that it has completed 60MM USD Series B+ financing led by MSA Capital, a globa... Biopharmaceuticals, Venture Capital Amador Bioscience
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news